350 rub
Journal №1 for 2013 г.
Article in number:
Intrinsic viscosity in quality analysis of plasma substitutes (for example with hydroxyethyl starch) and methods of analysis
Authors:
R.A. Lavrenchuk, I.V. Sakaeva, E.I. Sakanyan, E.B. Nechaeva, L.L. Kojemyakina
Abstract:
This article describes methods of viscosity determination of plasma substitute infusion solutions (for example, hydroxyethyl starch solutions), and experimental testing methods for determining viscosity. Plasma substitutes constitute a significant part of large-volume parenterals. Most of the plasma substitutes are aqueous solutions of hydroxyethyl starch of different molecular masses. Hydroxyethyl starch alter the rheological properties of solutions. For characterization of the rheological properties of the some medicines can be determined viscosity of different types. In some cases, the viscosity can further describe the molecular-mass characteristics of the active ingredients. These approaches are described in the actual domestic and in leading international documents and compendias. Analysis of the approved specifications showed both separately and jointly, using such characteristics as «Intrinsic viscosity» and «Relative viscosity» in its assessment of the rheological properties of the drug infusion of hydroxyethyl starch. In particular, use of the parameter «Intrinsic viscosity» in the analysis of plasma substitute solutions of hydroxyethyl starch allows evaluation of the viscosity of the solution and evaluation of the value of average molecular weight of the active pharmaceutical ingredient. In determining of this parameter are particularly important the analysis conditions and equipment used. In particular, the description of methods of determination, you must specify the exact temperature. The experimental results showed that temperature changes the viscosity of hydroxyethyl starch. Viscosity change was greater at higher concentrations of hydroxyethyl starch.
Pages: 14-18
References
  1. Oguz K. Baskurt, Herbert J. Meiselman. Blood rheology and Hemodynamics // Seminars in thrombosis and hemostasis. 2003. V. 29(5). P. 435-450.
  2. Государственный реестр лекарственных средств Российской Федерации. // URL: http://grls.rosminzdrav.ru/
  3. Standl T., Burmeister M.-A., Schroeder F. et al. Hydroxyethyl Starch (HES) 130/0,4 Provides Larger and Faster Increases in Tissue Oxygen Tension in Comparison with Prehemodilution Values than HES 70/0,5 or HES 200/0,5 in Volunteers Undergoing Acute Normovolemic Hemodilution // Anesthesia and analgesia. 2003. V. 96(4). P. 936-943.
  4. Государственная Фармакопея Российской Федерации,
    изд. XIIМ.: Научный центр экспертизы средств медицинского применения. 2008. С. 41-49.
  5. European Pharmacopoeia 7th edition // EDQM (European Directorate for the Quality of Medicines and Healthcare). 2011. Доступ по подписке. URL: http://online.edqm.eu/entry.htm The International Pharmacopoeia 4th edition // World Health Organization. URL: http://apps.who.int/phint/en/p/about/
  6. The Japanese Pharmacopeia 16th edition. 2011 // Pharmaceuticals and medical devices agency. P. 67-69. Систем. требования: Adobe Acrobat Reader. URL: http://www.pmda.go. jp/english/pharmacopoeia/pdf/jpdata/JP16eng.pdf
  7. United States Pharmacopeia 35th edition // United States Pharmacopeial Convention. Доступ по подписке. URL: http://www.uspnf.com/uspnf/login
  8. Тагер А.А. Физико-химия полимеров // М.: Химия. 1968. С. 408 - 417.